CytoTronics utilizes its licensed innovations from Harvard University to measure and manipulate live cells, producing real-time, high-resolution electrical and electrochemical cell-based assays. By providing unique single-cell resolution readouts, CytoTronics enhances the accuracy of cell-biology information, revolutionizing drug discovery. Founded in 2020 and based in Boston, Massachusetts.